Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 9, 2020
Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative
Anees Daud, Mandeep R Mehra, Alfonso Siu, et al.
JACC. Heart Failure
|
September 12, 2016
Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction
Avishay Grupper, Jose Nativi-Nicolau, Joseph J Maleszewski, et al.
JACC. Case Reports
|
March 18, 2026
Teclistamab Treatment Followed by Heart Transplantation for Advanced Immunoglobulin Light Chain Amyloid Cardiomyopathy
Mohamed Ibrahim, Ahmed Abdelhakeem, Grace Lin, et al.
European Journal of Heart Failure
|
April 29, 2021
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
Pablo Garcia-Pavia, Frank Bengel, Dulce Brito, et al.
Scientific Reports
|
November 11, 2023
Axillary mechanical circulatory support improves renal function prior to heart transplantation in patients with chronic kidney disease
Ji-Min Jang, Tambi Jarmi, Basar Sareyyupoglu, et al.
JAMA Cardiology
|
February 1, 2023
Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial
Brett W Sperry, Mazen Hanna, Mathew S Maurer, et al.
JACC. Heart Failure
|
March 7, 2015
Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure)
Omar F AbouEzzeddine, Phillip Haines, Susanna Stevens, et al.
Clinical Medicine Insights. Cardiology
|
May 4, 2026
Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE
Jose Nativi-Nicolau, Johana Fajardo, Alyssa Galloway, et al.
Circulation
|
June 2, 2020
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association
Michelle M Kittleson, Mathew S Maurer, Amrut V Ambardekar, et al.
ESC Heart Failure
|
September 8, 2025
Mid-term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support
Smruti Desai, Smit Paghdar, Jose Ruiz, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 9, 2020
Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative
Anees Daud, Mandeep R Mehra, Alfonso Siu, et al.
JACC. Heart Failure
|
September 12, 2016
Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction
Avishay Grupper, Jose Nativi-Nicolau, Joseph J Maleszewski, et al.
JACC. Case Reports
|
March 18, 2026
Teclistamab Treatment Followed by Heart Transplantation for Advanced Immunoglobulin Light Chain Amyloid Cardiomyopathy
Mohamed Ibrahim, Ahmed Abdelhakeem, Grace Lin, et al.
European Journal of Heart Failure
|
April 29, 2021
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
Pablo Garcia-Pavia, Frank Bengel, Dulce Brito, et al.
Scientific Reports
|
November 11, 2023
Axillary mechanical circulatory support improves renal function prior to heart transplantation in patients with chronic kidney disease
Ji-Min Jang, Tambi Jarmi, Basar Sareyyupoglu, et al.
JAMA Cardiology
|
February 1, 2023
Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial
Brett W Sperry, Mazen Hanna, Mathew S Maurer, et al.
JACC. Heart Failure
|
March 7, 2015
Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure)
Omar F AbouEzzeddine, Phillip Haines, Susanna Stevens, et al.
Clinical Medicine Insights. Cardiology
|
May 4, 2026
Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE
Jose Nativi-Nicolau, Johana Fajardo, Alyssa Galloway, et al.
Circulation
|
June 2, 2020
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association
Michelle M Kittleson, Mathew S Maurer, Amrut V Ambardekar, et al.
ESC Heart Failure
|
September 8, 2025
Mid-term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support
Smruti Desai, Smit Paghdar, Jose Ruiz, et al.
Page
of 8